Danaher announced it is voluntarily dividing into two separate publicly traded companies: Danaher and Fortive. Danaher is the parent company of DEXIS, Nobel Biocare, i-CAT, Pelton & Crane, KaVo Kerr Group, and others.
Danaher will continue to focus on health, science, and technology, according to a Washington Post article. The spin-off company, Fortive, will focus on "professional instrumentation and industrial technologies businesses," according to a Fortive release.
The spin-off will officially take place on July 2. Fortive will launch in the third quarter of 2016, according to the Danaher website.
At press time, the companies involved had not responded to requests for comment.
